New drug shows promise against dangerous virus in kidney transplants
Disease control
Completed
This study tested a drug called AntiBKV in 95 kidney transplant patients who had a BKV infection. The goal was to see if it could safely lower the virus levels and prevent kidney damage. Patients received four doses of the drug or a placebo over several weeks, with regular check-…
Phase: PHASE2, PHASE3 • Sponsor: Memo Therapeutics AG • Aim: Disease control
Last updated May 14, 2026 10:02 UTC